Literature DB >> 6652028

High-dose cytosine arabinoside (Ara-C) in colorectal cancer.

M Kanojia, H Kantarjian, J Ajani, B Barlogie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6652028      PMCID： PMC2011573          DOI： 10.1038/bjc.1983.280

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  4 in total

1.  A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine.

Authors:  R L Momparler
Journal:  Cancer Res       Date:  1974-08       Impact factor: 12.701

2.  Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).

Authors:  E Frei; J N Bickers; J S Hewlett; M Lane; W V Leary; R W Talley
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

3.  Dose: a critical factor in cancer chemotherapy.

Authors:  E Frei; G P Canellos
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

4.  Drugs five years later: cytarabine.

Authors:  W B Kremer
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.